Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Biochemical Society Transactions
|
August 28, 2024
Discovery of telomerase inhibitors: existing strategies and emerging innovations
Lauren Kageler, Elisa Aquilanti
Neurosurgery
|
April 18, 2020
Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons
Elisa Aquilanti, Priscilla K Brastianos
Expert Opinion on Pharmacotherapy
|
September 14, 2022
Current therapeutic options for glioblastoma and future perspectives
Elisa Aquilanti, Patrick Y Wen
Current Neurology and Neuroscience Reports
|
October 10, 2024
Novel Therapies for Primary Central Nervous System Lymphomas
Elisa Aquilanti, Elizabeth Herrity, Lakshmi Nayak
NPJ Precision Oncology
|
October 24, 2024
Therapeutic approaches to modulate the immune microenvironment in gliomas
Andreas Sarantopoulos, Chibawanye Ene, Elisa Aquilanti
Neuro-Oncology
|
September 2, 2021
Telomerase as a therapeutic target in glioblastoma
Elisa Aquilanti, Lauren Kageler, Patrick Y Wen, et al.
Neuro-Oncology
|
November 10, 2018
Updates in prognostic markers for gliomas
Elisa Aquilanti, Julie Miller, Sandro Santagata, et al.
Nucleic Acids Research
|
November 27, 2010
Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations
Yoshihiro Kino, Chika Washizu, Elisa Aquilanti, et al.
ACS Chemical Biology
|
June 10, 2025
High-Throughput Screening Tool to Identify Small Molecule Inhibitors of Telomerase
Elisa Aquilanti, Sulyman Barkho, Vincent Bozinov, et al.
Cancer Research
|
February 5, 2009
Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes
Yuri Kotliarov, Svetlana Kotliarova, Nurdina Charong, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Biochemical Society Transactions
|
August 28, 2024
Discovery of telomerase inhibitors: existing strategies and emerging innovations
Lauren Kageler, Elisa Aquilanti
Neurosurgery
|
April 18, 2020
Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons
Elisa Aquilanti, Priscilla K Brastianos
Expert Opinion on Pharmacotherapy
|
September 14, 2022
Current therapeutic options for glioblastoma and future perspectives
Elisa Aquilanti, Patrick Y Wen
Current Neurology and Neuroscience Reports
|
October 10, 2024
Novel Therapies for Primary Central Nervous System Lymphomas
Elisa Aquilanti, Elizabeth Herrity, Lakshmi Nayak
NPJ Precision Oncology
|
October 24, 2024
Therapeutic approaches to modulate the immune microenvironment in gliomas
Andreas Sarantopoulos, Chibawanye Ene, Elisa Aquilanti
Neuro-Oncology
|
September 2, 2021
Telomerase as a therapeutic target in glioblastoma
Elisa Aquilanti, Lauren Kageler, Patrick Y Wen, et al.
Neuro-Oncology
|
November 10, 2018
Updates in prognostic markers for gliomas
Elisa Aquilanti, Julie Miller, Sandro Santagata, et al.
Nucleic Acids Research
|
November 27, 2010
Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations
Yoshihiro Kino, Chika Washizu, Elisa Aquilanti, et al.
ACS Chemical Biology
|
June 10, 2025
High-Throughput Screening Tool to Identify Small Molecule Inhibitors of Telomerase
Elisa Aquilanti, Sulyman Barkho, Vincent Bozinov, et al.
Cancer Research
|
February 5, 2009
Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes
Yuri Kotliarov, Svetlana Kotliarova, Nurdina Charong, et al.
Page
of 3